Results 81 to 90 of about 73,668 (355)

Right atriotomy closure with modified ventricular assist device ring [PDF]

Journal of Cardiac Surgery, 2022
Journal of Cardiac Surgery, 37 (4)
Pia Lanmüller, Jaime‐Jürgen Eulert‐Grehn, Christoph Starck, Volkmar Falk, Evgenij Potapov   +4 more
openaire   +3 more sources

Limitations to Chronic Right Ventricular Assist Device Support [PDF]

The Annals of Thoracic Surgery, 2016
Failure of the right ventricle represents a significant clinical problem and may have different causes, with rates varying between 5% and 50% in patients supported by a left ventricular assist device (LVAD). However, treatment options and device development for right ventricular failure (RVF) have significantly lagged behind those for LVADs.
Randall C. Starling, David J. Horvath, Jamshid H. Karimov, Kiyotaka Fukamachi, Gengo Sunagawa, Nader Moazami, Nader Moazami   +6 more
openaire   +2 more sources

Contemporary outcomes of continuous-flow biventricular assist devices. [PDF]

, 2021
BACKGROUND: Significant right ventricular failure (RVF) complicating left ventricular assist device (LVAD) placement has been reported at 10–30%. Although primarily indicated for left ventricular failure, ventricular assist devices (VADs) have become ...
Bannon, Pg, Farag, J, Loforte, A, Marasco, Sf, Mcnamara, N, Potapov, Ev., Woldendorp, K   +6 more
core   +1 more source

Effects of the left ventricular assist device on right ventricular function

The Journal of Thoracic and Cardiovascular Surgery, 1990
Right ventricular failure is a leading cause of death in patients who require the left ventricular assist device. Previous reports suggested right ventricular functional deterioration during left ventricular assist but lacked a method by which right ventricular function could be quantified adequately. This study examined the effects of left ventricular
J. R. Elbeery, C H Owen, P VanTrigt, J. W. Davis, J S Rankin, M. A. Savitt, Michael P. Feneley   +6 more
openaire   +3 more sources

Pectus Excavatum and Risk of Right Ventricular Failure in Left Ventricular Assist Device Patients

Reviews in Cardiovascular Medicine, 2023
Background: Right ventricular failure (RVF) is a significant cause of morbidity and mortality in patients with a left ventricular assist device (LVAD).
Casper F. Zijderhand, Yunus C. Yalcin, Jelena Sjatskig, Daniel Bos, Alina A. Constantinescu, Olivier C. Manintveld, Ozcan Birim, Jos A. Bekkers, Ad J. J. C. Bogers, Kadir Caliskan   +9 more
doaj   +1 more source

Development of a Novel Echocardiography Ramp Test for Speed Optimization and Diagnosis of Device Thrombosis in Continuous-Flow Left Ventricular Assist Devices The Columbia Ramp Study [PDF]

, 2012
ObjectivesThis study sought to develop a novel approach to optimizing continuous-flow left ventricular assist device (CF-LVAD) function and diagnosing device malfunctions.BackgroundIn CF-LVAD patients, the dynamic interaction of device speed, left and ...
Colombo, Paolo C., Flannery, Margaret, Garan, Arthur R., John, Ranjit, Jorde, Ulrich P., Kato, Tomoko S., Latif, Farhana, Mancini, Donna M., Morrison, Kerry A., Naka, Yoshifumi, Restaino, Susan W., Takayama, Hiroo, Uriel, Nir, Yuzefpolskaya, Melana   +13 more
core   +1 more source

Minimally invasive surgery for left ventricular assist device implantation is safe and associated with a decreased risk of right ventricular failure

Journal of Thoracic Disease, 2020
Background Right ventricular failure (RVF) after left ventricular assist device (LVAD) implantation is associated with significant mortality and morbidity.
A. Carmona, Tam Hoang Minh, Stephanie L Perrier, Clément Schneider, Sandrine Marguerite, G. Ajob, Cristina I. Mircea, P. Mertes, Darmesh Ramlugun, J. Atlan, J. Von Hunolstein, E. Epailly, J. Mazzucotelli, M. Kindo   +13 more
semanticscholar   +1 more source

Assessment of Right Ventricular Function in Left Ventricular Assist Device Candidates [PDF]

Circulation: Cardiovascular Imaging, 2014
As a result of the improved survival of patients with heart failure (HF) and the overall rise in the prevalence of HF,1 the number of patients in advanced (stage D) HF continues to increase, thus exceeding the limited availability of donor organs by a wide margin.2 Initially used primarily as a bridge to heart transplantation, mechanical circulatory ...
Andreas P. Kalogeropoulos, Salim S. Hayek, Javed Butler, David W. Markham, Daniel B. Sims   +4 more
openaire   +3 more sources

Biologically‐Inspired Melt Electrowriting for the Generation of Highly Biomimetic Functional Myocardium

Advanced Functional Materials, EarlyView.
In this work, melt electrowriting is used to fabricate a 3D printed scaffold design that generates engineered cardiac tissues with in‐plane contraction, mimicking natural myocardium. It is shown that these tissues display advanced maturation and functionality.
Olalla Iglesias‐García, María Flandes‐Iparraguirre, Pilar Montero‐Calle, Ricardo M. Rosales, Asier Ullate‐Agote, Andrea Sánchez‐Bueno, Eduardo Larequi, Ilazki Anaut‐Lusar, Nicolás Laita, Aida Oliván‐Viguera, Elena Iglesias, Gloria Abizanda, Patxi San Martín‐Úriz, Paula Aguirre‐Ruiz, Xabier L. Aranguren, Manuel García de Yébenes, Juan José Gavira, Miguel Ángel Martínez, Estefanía Peña, Manuel Doblaré, Elena M. de‐Juan‐Pardo, Esther Pueyo, Felipe Prosper, Manuel M. Mazo Vega   +23 more
wiley   +1 more source

Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure

ESC Heart Failure, 2023
Aims Phosphodiesterase‐5 inhibitors (PDE5I) are frequently implemented after left ventricular assist device (LVAD) implantation to improve haemodynamics in patients with early postoperative right ventricular (RV) failure. It is unknown if long‐term PED5I
Maria Papathanasiou, Aiste‐Monika Jakstaite, Raluca Mincu, Simon Wernhart, Arjang Ruhparwar, Tienush Rassaf, Peter Luedike   +6 more
doaj   +1 more source